Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Lawreshwar IPO and SMS Pharmaceuticals IPO.
Lawreshwar IPO is a Mainline Book Built Issue IPO proposed to list at BSE while SMS Pharmaceuticals IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Lawreshwar IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | BSE | BSE, NSE |
| Lead Managers | Ashika Capital Ltd | Uti Securities Ltd |
| Registrar | Maheshwari Datamatics Pvt. Ltd | Aarthi Consultants Pvt Ltd. |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Lawreshwar IPO is up to ₹13.94 Cr whereas the issue size of the SMS Pharmaceuticals IPO is up to ₹97.93 Cr. The final issue price of Lawreshwar IPO is ₹16.00 per share and of SMS Pharmaceuticals IPO is ₹380.00 per share.
| Lawreshwar IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹360.00 per share | |
| Issue Price (Upper) | ₹380.00 per share | |
| Issue Price (Final) | ₹16.00 per share | ₹380.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 400 shares | 15 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 87,12,500 shares | 25,77,000 shares |
| Issue Size Total (Amount) | up to ₹13.94 Cr | up to ₹97.93 Cr |
Lawreshwar IPO opens on Feb 05, 2007, while SMS Pharmaceuticals IPO opens on Feb 05, 2007. The closing date of Lawreshwar IPO and SMS Pharmaceuticals IPO is Feb 08, 2007, and Feb 08, 2007, respectively.
| Lawreshwar IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 05, 2007 | Feb 05, 2007 |
| Issue Close | Feb 08, 2007 | Feb 08, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Lawreshwar IPO P/E ratio is , as compared to SMS Pharmaceuticals IPO P/E ratio of .
| Lawreshwar IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 100% | 72.31% |
| Promoter Shareholding (Post-Issue) | 54.31% | 53.68% |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 7.27%% | 17.41%% |
In the Lawreshwar IPO retail investors (RII) are offered while in SMS Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Lawreshwar IPO and in SMS Pharmaceuticals IPO.
| Lawreshwar IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Lawreshwar IPO subscribed in total, whereas SMS Pharmaceuticals IPO subscribed 2.64x.
| Lawreshwar IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 3.47x | |
| NII (times) | 0.28x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.47x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.64x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
